Goldman Sachs’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,733,556
Closed -$300M 7688
2015
Q1
$300M Buy
1,733,556
+611,026
+54% +$89.7M 0.12% 213
2014
Q4
$129M Buy
1,122,530
+236,813
+27% +$28.7M 0.06% 556
2014
Q3
$138M Buy
885,717
+396,345
+81% +$57.5M 0.06% 491
2014
Q2
$60.4M Buy
489,372
+199,997
+69% +$22.1M 0.02% 962
2014
Q1
$30M Buy
289,375
+176,801
+157% +$18.1M 0.01% 1431
2013
Q4
$10.1M Sell
112,574
-30,839
-22% -$2.46M ﹤0.01% 2350
2013
Q3
$9.59M Buy
143,413
+33,075
+30% +$2.28M 0.01% 2299
2013
Q2
$7.3M Buy
+110,338
New +$6.31M ﹤0.01% 2365

Other funds holding SLXP